A dentist must have an active dental license to prescribe medicines. To prescribe controlled substances, a dentist also must be registered with the U.S. Drug Enforcement Administration. No other state registration is required.
Information and DEA registration application are available on the DEA website, https://www.deadiversion.usdoj.gov/drugreg/index.html. A DEA registration number is site specific. Before applying for a DEA number, a dentist should ensure their address in the dental board records is the same address they are using on the DEA application. If a dentist administers or dispenses a controlled substance at more than one office, then the dentist must obtain separate DEA registration numbers for each location (the board requires dentists to report each place of practice). Additional DEA registrations are not required if a dentist only prescribes at other office locations within California and does not administer or dispense controlled substances there.
The DEA permits an individual practitioner, such as a locum tenens dentist, to use a home address as the principal place of business. In such cases, the location is considered a “controlled premises” and is subject to unannounced inspections and administrative warrants. Recordkeeping and security requirements remain the same.
Practitioners may not use a P.O. box or private mailing box address for DEA registration.
The law does not require it. However, a dental benefit plan may require a dentist to be registered with the DEA as part of its credentialing process. Always check with each contracted plan prior to giving up a DEA registration.
Electronic data transmission prescriptions are mandated in California as of Jan. 1, 2022. However, recent legislation expanded the permitted exceptions to the mandate. Starting Jan. 1, 2023, prescribers who issue 100 or fewer prescriptions per calendar year are exempt from the mandate as long as they register annually with the board of pharmacy. Additional information is included in this article.
E-prescribing provides timely patient care and reduces opportunities for diversion of controlled substances by eliminating the use of paper forms that can be stolen, lost or left behind and used illegally. Prescribing software is available with or without the ability to electronically prescribe controlled substances. EPCS software costs more due to the additional costs of regulatory compliance.
These are factors to consider when purchasing prescribing software:
EPCS software must be certified that it complies with the DEA regulation adopted in June 2010. The regulation established procedures that include:
A prescriber must undergo an identity-proofing process, which includes submission of a dental license, DEA registration and NPI Type 1 number. Once a prescriber’s identity is proved, the prescriber will receive the credentials necessary to sign a controlled substance prescription. If a prescriber works at multiple locations with different prescribing software, each location’s software vendor will determine the necessity of the prescriber undergoing identity proofing more than once.
The DEA requires the use of two-factor authentication for signing a controlled substance prescription. The factors must be two of the following:
The prescriber may not give any of the factors to another individual; doing so may lead to revocation or suspension of the prescriber’s DEA registration. A staff member may enter information into an e-prescription but only the prescriber may “sign” by submitting the two factors to the prescribing system.
Setting access controls requires at least two individuals, one of whom must be a DEA registrant with active EPCS privilege. One or both individuals can be set up as administrators in the system, depending on the software. The non-DEA registrant is responsible for ensuring the DEA registrant’s credentials are current. The administrator also is responsible for regularly reviewing internal audit reports and reporting security incidents as soon as possible to the software vendor and to the DEA.
Additional information is available from the DEA and from individual EPCS vendors.
A prescriber with an EHR should check with that company. E-prescribing, with or without EPCS, can be added to Dentrix, Eaglesoft, OpenDental, Curve, Carestream or MacPractice. A list of prescribing software applications is available on a Surescripts website; however, many are proprietary products associated with a specific EHR or an entity such as Aspen Dental. Listed here are some stand-alone prescribing software applications with EPCS:
CDA has endorsed two e-prescribing applications – iCoreRx and Henry Schein One ePrescribe. More information is available on the Endorsed Services website.
A pharmacy is required to notify the prescriber immediately once it becomes aware that an electronic data transmission prescription failed, is incomplete or is otherwise not appropriately received. The failure need not inconvenience a patient because pharmacists may continue to dispense medicine from legally valid written, oral or fax prescription.
Include the patient’s Kaiser medical record number in the “notes to the pharmacy” section on each prescription for the same patient.
Under any of the above conditions, a prescription shall be issued electronically but does not require electronic transmission and may be provided directly to the patient.
To remain exempt, a prescriber must annually register with the pharmacy board and maintain documentation of the circumstances qualifying them for exemption. (Information on the registration procedure will be included here once it is established.) The pharmacy board will post a list of registered prescribers on its website.
The electronic data prescription mandate does not apply when providing health care services to an inmate, an individual on parole or youth under the jurisdiction of the Department of Corrections and Rehabilitation.
Be aware that patients with prescription drug benefits under Medicare/Medicaid must have their prescriptions submitted by electronic data transmission in order for the program to pay for it.
Yes, but only in situations that qualify as an exception to the mandate for electronic data transmission prescribing.
Only in an emergency situation may a prescriber phone in a prescription for a Schedule II drug, and this action is subject to several limitations. Additionally, a pharmacist is subject to several restrictions and requirements in fulfilling such a prescription. Notable requirements for prescribers phoning in an emergency prescription for a Schedule II drug include:
If a prescriber is exempt from using electronic data transmission prescriptions, they must ensure paper prescription forms comply with state requirements. Prescriptions for non-controlled substances may be written on a tamper-resistant form or a form that meets the requirements of Business & Professions Code §4040, or be orally transmitted to the pharmacy.
Prescription forms for non-controlled substances must include all of the following:
Written prescriptions for controlled substances must be on tamper-resistant forms printed by state-approved printers with these required elements detailed in Health & Safety Code §11162.1:
Each batch of controlled substances prescription forms must have a lot number printed on the form and each form within that batch will be numbered sequentially beginning with the numeral one.
The loss or theft of tamper-resistant prescription forms must be reported by a prescriber through CURES no later than three days after discovering the loss or theft.
A pharmacist may select another drug product with the same active chemical ingredients of the same strength, quantity and dosage form and the same generic drug name of those drug products with the same active chemical ingredients. However, in no case shall a substitution be made if the prescriber checks a box indicating “Do not substitute” or words of similar meaning on the e-prescription.
Reference: Business & Professions Code §4073.
A pharmacist’s license is at risk whenever they fill a prescription. The pharmacist has a professional responsibility to ensure the prescribed medication is appropriate for the patient and within the prescriber’s scope of practice. Many pharmacists expect dentist-generated prescriptions to be for antibiotics or for relief of acute pain. Prescriptions for medicines not typically associated with oral disorders or for controlled substances for an extended time can raise red flags.
Dentists and pharmacists must work together for the patient’s benefit. It can help to introduce yourself to local pharmacies and the respective pharmacists in charge. Send a letter of introduction that includes a description of your practice and any education/training you have had that supports the type of prescriptions you write. A practice, for example, that focuses on TMD/TMJ cases may generate prescriptions outside what is typically expected from a general dentist.
If your patient uses a pharmacy that is unfamiliar with you and you have provided an atypical prescription, include a note to the pharmacist that provides your rationale or that asks the pharmacist to contact you to discuss the patient’s case. For example, a pharmacy may question your prescription of one antibiotic instead of another, but you can use your patient’s history to demonstrate that the patient responds best to the antibiotic you prescribe.
Building a professional relationship with pharmacists helps your patients and your practice.
Yes, you may issue a prescription for a family member if the family member is a patient of record and the prescription is related to treatment you are providing. A prescription for controlled substances for a family member, however, may be filled only in specific circumstances on an interim basis.
Any prescription written by a dentist must be in conjunction with dental treatment provided by the dentist. There are limited exceptions to this rule.
All prescribers and dispensers of controlled substances must register to access CURES (Controlled Substance Utilization Review and Evaluation System), the state’s prescription drug monitoring database managed by the state Department of Justice. In addition to checking the database, prescribers must regularly report the dispensing of controlled substances through the DOJ’s third-party vendor (dispensing medication is not the same as administering it).
A prescriber is required to check CURES for a patient’s controlled substances prescription history before prescribing a Schedule II-IV drug. The intent of the requirement is to assist prescribers in making better prescribing decisions and to cut down on prescription drug abuse. One exception to this requirement is:
. . . if a health care practitioner prescribes, orders, administers, furnishes or dispenses a controlled substance to a patient as part of the patient's treatment for a surgical procedure, if the quantity of the controlled substance does not exceed a nonrefillable five-day supply of the controlled substance to be used in accordance with the directions for use . . .
If the controlled substance remains part of the patient’s treatment, a dentist must subsequently check the CURES database prior to writing another prescription and every four months while the substance is part of the patient’s treatment. The CURES patient activity report must be pulled no earlier than 24 hours prior to prescribing.
Additional information on CURES registration, patient activity reports, account maintenance and more is in “CURES Frequently Asked Questions.”
Prescribers who dispense controlled substances must comply with federal law (summarized in the DEA’s resource A Practitioner’s Manual) and with state law. Some of these requirements include:
Controlled substance samples provided by pharmaceutical companies must be included in the inventory record.
Schedule II controlled substances may not be dispensed at free or nonprofit clinics.
A prescriber is required to discuss the following information with the minor, the minor’s parent or legal guardian prior to dispensing or issuing to the minor the first prescription in a single course of treatment for a controlled substance containing an opioid:
The requirement does not apply when the patient is undergoing treatment for drug addiction or chronic pain or emergency surgery or care. If the provision of the above information would be detrimental to the minor’s health or safety or in violation of the minor’s legal rights regarding confidentiality in the prescriber’s professional judgment, the prescriber need not provide the information. See “Consent to Prescribe Opioid to a Minor.”
A prescriber must offer to a patient a prescription for naloxone hydrochloride or other FDA-approved drugs for the complete or partial reversal of opioid depression when one or more of the following conditions are present:
Additionally, a prescriber must provide education to a patient, or a patient’s guardian if the patient is a minor, receiving a prescription per the above circumstance on overdose prevention and the use of naloxone hydrochloride or other FDA-approved drugs for the complete or partial reversal of opioid depression.
A prescriber who wishes to discontinue administering, prescribing and dispensing controlled substances must submit written notification of registration termination to the nearest DEA field office. The notification must be accompanied by the DEA Certificate of Registration and any unused Official Order Forms (DEA Form-222).
Keep in mind that a dental benefit plan may require a dentist to be registered with the DEA as part of its credentialing process. Always check with each contracted plan prior to giving up a DEA registration.
Use an authorized mail-back program or “reverse distributor” to dispose of controlled substances. Contact a local DEA field office for a list of authorized reverse distributors. Maintain copies of the records documenting the transfer and disposal of controlled substances for two years.
Prescribers should encourage patients to properly dispose of their unused or expired controlled substances through their local pharmacy or take-back event sponsored by local law enforcement.
Oxycodone combination products (Percodan, Percocet)
Tylenol #3 (with codeine)
*Hydrocodone combination products (Vicodin, Vicoprofen, Lortab, Lorcet, Norco)
Yes. Prior to dispensing medication, a prescriber must offer a written prescription to the patient that the patient may elect to have filled by the dentist or by any pharmacy. The prescriber must also provide the patient with a written disclosure that the patient has a choice between obtaining the prescription from you, the dentist, or obtaining the prescription at a pharmacy of the patient’s choice.
No. Any medication dispensed by a dentist to a patient must be in conjunction with dental treatment provided by the dentist.
Drugs to be dispensed must be stored in a secure area, which means a locked storage area within the dentist’s office. The keys to the locked storage area shall be available only to staff authorized by the dentist. A record or log of drug acquisition and disposition must be maintained by the dentist. Records must be preserved for three years.
A dentist may furnish to a patient at no charge a limited quantity of drug samples if furnished in the package provided by the manufacturer. This transaction should be recorded in the patient record.
No. State law requires prescribers who dispense to follow all the packaging requirements of good pharmaceutical practice, including the use of childproof containers.
Label requirements are intended to provide patients with easy-to-read labels. The following elements must be printed in at least 12-point sans serif typeface, listed in the following order and clustered into one area of the label that comprises at least 50 percent of the label:
This part of the label must be highlighted in bold typeface or color or have blank space to set off the above items.
The remaining required elements of the label must be printed so as not to interfere with the legibility of the four elements listed above. The remaining required elements are:
Upon the request of a patient or patient’s representative, a prescriber who dispenses must provide translated directions for use on the prescription container, label or on a supplemental document. (An example of directions for use is “Take one pill at bedtime.”) The English-language version of the directions for use must also appear on the container or label (not on a supplemental document). The California State Board of Pharmacy has translated directions online in Chinese, Korean, Russian, Spanish and Vietnamese. A dispenser may provide their own translated directions for use or can use the translations made available by the Board of Pharmacy. The prescriber dispenser is not obligated to provide translated directions for use beyond the languages that the pharmacy board has made available or beyond the directions that the board has made available in translated form.
When applicable, directions for use must use one of the 16 directions listed in Section 1707.5 of Title 16 of the California Code of Regulations. The one likely to be used by dental practices is:
“If you have pain, take __ (insert appropriate dosage form — pill, caplet, capsule or tablet) at a time. Wait at least __ hours before taking again. Do not take more than __ (appropriate dosage form) in one day.”
Many of the 16 directions are variations of the following:
“Take two (insert appropriate dosage form) in the morning and take two (insert appropriate dosage form) at bedtime.”
The regulation, which contains the list of directions, is available on the pharmacy board website. All possible directions for use are not included in the regulation. If a prescription’s directions for use is not included in the regulation, the prescriber dispenser is not required to use one listed in the regulation. Also, inform the patient of possible side effects of the drug. This information does not have to be on the label. False or misleading information may not be included on a prescription label.
Samples of patient-centered prescription drug container labels can be found on the pharmacy board website.
This is categorized as pharmaceutical waste, a type of regulated medical waste. Refer to “Dental Office Waste Management Options” on cda.org/practice support for more information.
Health & Safety Code §11000 et seq. -
Business & Professions Code §§ 4040, 4070-4078, 4080-4081, 4105, 4170-4175, 4184
California Code of Regulations Title 16 §§1356.3 and 1707.5
Already a CDA Member?
to keep exploring our resource library.
Learn more about CDA Member Benefits.
Go back to the previous page.